Atea Pharmaceuticals, Inc. (AVIR) Free cash flow 2018–2022
Atea Pharmaceuticals, Inc. (AVIR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$122.9MFY2022 · since FY2018: -$7.9M → -$122.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$122.9M | -41.3% |
| FY2021 | -$87.0M | -129.3% |
| FY2020 | $296.7M | +2412.4% |
| FY2019 | -$12.8M | -62.0% |
| FY2018 | -$7.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice